Drug class review: Second generation antidepressants final report update 4

Axis I psychiatric disorders such as depressive disorder, anxiety disorder, adjustment disorder, and premenstrual disorders are serious disabling illnesses. Newer treatments for these disorders include selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, and oth...

Full description

Main Author: Gartlehner, Gerald
Corporate Authors: Research Triangle Institute-University of North Carolina Evidence-based Practice Center, Cecil G. Sheps Center for Health Services Research, Oregon Health & Science University Evidence-based Practice Center, Oregon Health & Science University, Drug Effectiveness Review Project
Format: eBook
Language:English
Published: Portland, OR Oregon Health & Science University 2008, c2008
Series:Drug class reviews
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Summary:Axis I psychiatric disorders such as depressive disorder, anxiety disorder, adjustment disorder, and premenstrual disorders are serious disabling illnesses. Newer treatments for these disorders include selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, and other second-generation drugs. The purpose of this review is to evaluate the comparative evidence on benefits and harms of these medications in people with depression to help policymakers and clinicians make informed choices about the use of selective serotonin reuptake inhibitors and newer antidepressants
Item Description:Title from PDF title page (viewed July 20, 2011)
Physical Description:1 online resource